Arthur S. Kirsch, Director at Aralez Pharmaceuticals Inc. (ARLZ), bought 50,000 shares at $1.17 ($59K) on 2017-06-14, disclosed to the SEC on 2017-06-16.
Open-market purchase of $58k ARLZ by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| LQDA | BUY | 2021-11-12 | $127K | — | Filing → |
| LQDA | BUY | 2018-11-15 | $18K | — | Filing → |
| LQDA | BUY | 2018-11-13 | $18K | — | Filing → |